HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 82 filers reported holding HARROW HEALTH INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,965,968 | -37.8% | 206,400 | -17.6% | 0.01% | -33.3% |
| Q2 2023 | $4,771,424 | -27.2% | 250,600 | -19.1% | 0.01% | -29.4% |
| Q1 2023 | $6,553,252 | +211.8% | 309,700 | +117.5% | 0.02% | +183.3% |
| Q4 2022 | $2,101,824 | +79.3% | 142,400 | +46.7% | 0.01% | +100.0% |
| Q3 2022 | $1,172,000 | +23.6% | 97,100 | -25.4% | 0.00% | 0.0% |
| Q2 2022 | $948,000 | +23.6% | 130,200 | +15.7% | 0.00% | +50.0% |
| Q1 2022 | $767,000 | -42.6% | 112,500 | -27.2% | 0.00% | -33.3% |
| Q4 2021 | $1,336,000 | -36.8% | 154,622 | -33.5% | 0.00% | -40.0% |
| Q3 2021 | $2,114,000 | -20.9% | 232,600 | -19.2% | 0.01% | -28.6% |
| Q2 2021 | $2,673,000 | +88.5% | 287,700 | +37.0% | 0.01% | +75.0% |
| Q1 2021 | $1,418,000 | +62.4% | 210,000 | +65.0% | 0.00% | +100.0% |
| Q4 2020 | $873,000 | +57.0% | 127,300 | +28.1% | 0.00% | 0.0% |
| Q3 2020 | $556,000 | – | 99,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,343,817 | $40,360,000 | 16.67% |
| Invenire Partners, LP | 453,794 | $5,477,293,000 | 8.38% |
| Acuitas Investments, LLC | 337,949 | $4,079,000 | 4.23% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 188,539 | $2,276,000 | 2.47% |
| Ophir Asset Management Pty Ltd | 1,714,464 | $20,694,000 | 1.88% |
| Private Capital Management, LLC | 1,029,356 | $12,424,000 | 1.80% |
| Birchview Capital, LP | 180,000 | $2,173,000 | 1.53% |
| Diametric Capital, LP | 224,090 | $2,705,000 | 1.36% |
| Uniplan Investment Counsel, Inc. | 694,257 | $8,379,000 | 0.64% |
| EAM Investors, LLC | 224,046 | $2,704,000 | 0.59% |